Literature DB >> 30793766

Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis.

Dang Quan Nguyen1, Dinh Hoa Hoang2, Thanh Thao Vo Nguyen1, Huu Duc Ho3, Vu Huynh1, June Ho Shin4, Quoc Trung Ly5, Dai Dong Thi Nguyen6, Lucy Ghoda2, Guido Marcucci2, Le Xuan Truong Nguyen1,2.   

Abstract

The ErbB3-binding protein 1 (Ebp1) has been reported as either an oncogenic regulator or a tumor suppressor in a variety of cancers. Here, we show that Ebp1 p48, a predominant expression isoform, is highly expressed in the majority of human colon tumor cells compared with normal adjacent tissues and its expression is required for the oncogenic activities of these cells. Depletion of Ebp1 expression in primary colon cancer cells inhibits cell proliferation, colony forming, and invasion in vitro as well as tumor formation in vivo and enhances cell sensitivity to irradiation. We further demonstrated that Ebp1 interacts with TIF-90, a splice variant of transcription initiation factor IA (TIF-IA) of the RNA polymerase I complex, allowing for regulation of ribosomal RNA (rRNA) synthesis and oncogenesis in human colon cancer cells. Moreover, Ebp1 expression is essential for Akt protected TIF-90 stability by preventing TIF-90's ubiquitination by Mdm2 and hence, its proteasomal degradation. The results of the present study support a mechanism of underlying oncogenic activities by means of Ebp1 through regulation of TIF-90-mediated rRNA synthesis and suggest the potential therapeutic treatment of colon cancer by targeting Ebp1 and its signaling.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ebp1; TIF-90; colon cancer; rRNA synthesis

Mesh:

Substances:

Year:  2019        PMID: 30793766     DOI: 10.1002/jcp.28385

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  ErbB-3 BINDING PROTEIN 1 Regulates Translation and Counteracts RETINOBLASTOMA RELATED to Maintain the Root Meristem.

Authors:  Ansul Lokdarshi; Csaba Papdi; Aladár Pettkó-Szandtner; Stefan Dorokhov; Ben Scheres; Zoltán Magyar; Albrecht G von Arnim; László Bögre; Beatrix M Horváth
Journal:  Plant Physiol       Date:  2019-12-09       Impact factor: 8.340

2.  PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.

Authors:  Sheng Sun; Yiyang Liu; Meiling Zhou; Jinyuan Wen; Lin Xue; Shenqi Han; Junnan Liang; Yufei Wang; Yi Wei; Jinjin Yu; Xin Long; Xiaoping Chen; Huifang Liang; Zhao Huang; Bixiang Zhang
Journal:  Cell Biosci       Date:  2022-05-07       Impact factor: 7.133

3.  Dynamic association of human Ebp1 with the ribosome.

Authors:  Varun Bhaskar; Jessica Desogus; Alexandra Graff-Meyer; Andreas D Schenk; Simone Cavadini; Jeffrey A Chao
Journal:  RNA       Date:  2021-01-21       Impact factor: 4.942

4.  ERBB3 binding protein 1 promotes the progression of malignant melanoma through activation of the Wnt/ β-catenin signaling pathway.

Authors:  Yanqiu Bao; Jingshu Cui; Yuyang Yue; Shuxia Cao; Xiangdan Li; Lan Liu
Journal:  Cancer Cell Int       Date:  2022-01-29       Impact factor: 5.722

Review 5.  Ribosome Biogenesis Alterations in Colorectal Cancer.

Authors:  Sophie Nait Slimane; Virginie Marcel; Tanguy Fenouil; Frédéric Catez; Jean-Christophe Saurin; Philippe Bouvet; Jean-Jacques Diaz; Hichem C Mertani
Journal:  Cells       Date:  2020-10-27       Impact factor: 6.600

6.  Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism.

Authors:  Dinh Hoa Hoang; Corey Morales; Ivan Rodriguez Rodriguez; Melissa Valerio; Jiamin Guo; Min-Hsuan Chen; Xiwei Wu; David Horne; Varsha Gandhi; Lisa S Chen; Bin Zhang; Vinod Pullarkat; Steven T Rosen; Guido Marcucci; Ralf Buettner; Le Xuan Truong Nguyen
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.